Literature DB >> 9472299

The epidemiology of cutaneous leishmaniasis in subtropical Ecuador.

R X Armijos1, M M Weigel, R Izurieta, J Racines, C Zurita, W Herrera, M Vega.   

Abstract

An epidemiologic survey (n = 466) was conducted in an area of subtropical rainforest in north-west Ecuador with the following objectives: (1) to determine the prevalence of cutaneous leishmaniasis (CL), (2) to identify the Leishmania species causing human disease, (3) to investigate the major clinical manifestations of leishmaniasis, (4) to study cellular and humoral immune response indicators associated with disease status and (5) to identify risk factors for CL. Fourteen percent of subjects had parasitologically confirmed CL; 33% had evidence of prior disease. However, 17.2% of subjects with a negative CL clinical history presented with a positive Montenegro skin test (MST), indicating the possibility of subclinical infection. The species isolated from subject lesions were L. guyanensis (63%), L. panamensis (33%), and L. brazilensis (4%). Mean specific anti-Leishmania IgG and IgM OD serum levels were highest in subjects diagnosed with current CL, followed by those with prior CL, and were lowest in healthy subjects, respectively (0.56 +/- 0.27 vs 0.33 +/- 0.2 vs 0.22 +/- 0.14; F-ratio = 74; P < 0.00001) and (665 +/- 270 vs 481 +/- 220 vs 301 +/- 128.5; F-ratio = 37; P < 0.00001). Likewise, subjects with present CL had measurably higher MST reactions (13 +/- 6.7 mm) than those with prior CL (10.9 +/- 7.8 mm) or healthy individuals (2.4 +/- 2.5 mm; F-ratio = 106; P < 0.00001). Serum concentrations of IgG were predicted by lesion number (t = 2.5; P = 0.018), size (t = 3.7; P = 0.0006), and duration (t = 3.5; P = 0.0013). Furthermore, the MST induration size increased as a function of lesion number (t = 3.0; P = 0.005) and size (t = 3.4; P = 0.022). Subject age and sex did not predict serum IgG or IgM concentrations or MST reactions in the 3 disease groups. Although no sex differences were found with respect to clinical characteristics, children < or = 12 years of age were almost 3 times more likely to have CL lesions or scars located on the face and head area compared to adults (OR = 2.75; 95% CI = 1.4-5.6, P = 0.004). The risk factors associated with disease included age under 5 years (AOR = 1.5; 95% CI = 0.48-2.35), male gender in adults (AOR = 2.8; 95% CI = 1.1-7.8), and wood and/or cane exterior house walls (AOR = 1.8; 95% CI = 1.4-2.5). In contrast, electric home lighting was associated with decreased risk (AOR = 0.7; 95% CI = 0.4-2.3). The results suggest that it may be possible to modify a portion of the risk of CL by making changes in the housing environment which may help to reduce the amount of human-vector contact.

Entities:  

Mesh:

Year:  1997        PMID: 9472299     DOI: 10.1046/j.1365-3156.1997.d01-236.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  14 in total

1.  Coinfection of Leishmania guyanensis and Human Immunodeficiency Virus-Acquired Immune Deficiency Syndrome: Report of a Case of Disseminated Cutaneous Leishmaniasis in Ecuador.

Authors:  Manuel Calvopina; Cristina Aguirre; William Cevallos; Alberto Castillo; Ibrahim Abbasi; Alon Warburg
Journal:  Am J Trop Med Hyg       Date:  2017-02-13       Impact factor: 2.345

2.  Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp.

Authors:  Bruno L Travi; Yaneth Osorio; Peter C Melby; Bysani Chandrasekar; Lourdes Arteaga; Nancy G Saravia
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

3.  Differences in gamma interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers.

Authors:  M M Pompeu; C Brodskyn; M J Teixeira; J Clarêncio; J Van Weyenberg; I C Coelho; S A Cardoso; A Barral; M Barral-Netto
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

4.  Intralesional Infiltration with Meglumine Antimoniate for the Treatment of Leishmaniasis Recidiva Cutis in Ecuador.

Authors:  Manuel Calvopiña; William Cevallos; Yolanda Paredes; Edison Puebla; Jessica Flores; Richard Loor; José Padilla
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

5.  Environmental and socioeconomic risk factors associated with visceral and cutaneous leishmaniasis: a systematic review.

Authors:  Nerida Nadia H Valero; María Uriarte
Journal:  Parasitol Res       Date:  2020-01-02       Impact factor: 2.289

6.  Cutaneous leishmaniasis "chiclero's ulcer" in subtropical Ecuador.

Authors:  Manuel Calvopiña; Leonardo Martinez; Yoshihisa Hashiguchi
Journal:  Am J Trop Med Hyg       Date:  2013-08       Impact factor: 2.345

7.  Leishmania isoenzyme polymorphisms in Ecuador: relationships with geographic distribution and clinical presentation.

Authors:  Manuel Calvopina; Rodrigo X Armijos; Jorge D Marco; Hiroshi Uezato; Hirotomo Kato; Eduardo A Gomez; Masataka Korenaga; Paola A Barroso; Tatsuyuki Mimori; Philip J Cooper; Shigeo Nonaka; Yoshihisa Hashiguchi
Journal:  BMC Infect Dis       Date:  2006-09-13       Impact factor: 3.090

8.  Prevalence and determinants of Leishmania major infection in emerging and old foci in Tunisia.

Authors:  Jihene Bettaieb; Amine Toumi; Sadok Chlif; Bilel Chelghaf; Aicha Boukthir; Adel Gharbi; Afif Ben Salah
Journal:  Parasit Vectors       Date:  2014-08-20       Impact factor: 3.876

9.  Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments.

Authors:  José A O'Daly; Humberto M Spinetti; Joe Gleason; María B Rodríguez
Journal:  J Parasitol Res       Date:  2013-06-13

Review 10.  Co-infection of tuberculosis and parasitic diseases in humans: a systematic review.

Authors:  Xin-Xu Li; Xiao-Nong Zhou
Journal:  Parasit Vectors       Date:  2013-03-22       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.